Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Northwest Bancshares's Marketable Securities for the quarter that ended in Mar. 2026 was €1,511.1 Mil.
Northwest Bancshares's annual Marketable Securities
increased
from Dec. 2023 (€956.8 Mil) to Dec. 2024 (€1,059.0 Mil) and
increased
from Dec. 2024 (€1,059.0 Mil) to Dec. 2025 (€1,354.8 Mil).
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Northwest Bancshares Marketable Securities Related Terms
Northwest Bancshares Marketable Securities Historical Data
* Premium members only.
The historical data trend for Northwest Bancshares's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of €1,511.1 Mil mean?
Northwest Bancshares (FRA:NHS) has a Marketable Securities of €1,511.1 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Northwest Bancshares and its competitors.
Is Northwest Bancshares' Marketable Securities too high?
Northwest Bancshares' current Marketable Securities is €1,511.1 Mil. Overall, Northwest Bancshares has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Northwest Bancshares' Marketable Securities compare to SYBT and CLBK?
Northwest Bancshares' Marketable Securities of €1,511.1 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Banks company?
A good Marketable Securities depends on the Banks industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Northwest Bancshares and its competitors. Northwest Bancshares's current Marketable Securities is €1,511.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Northwest Bancshares stock overvalued right now?
Based on GuruFocus' analysis, Northwest Bancshares (FRA:NHS) is currently considered Modestly Overvalued. The stock's GF Value™ is €10.39, compared to a current price of €13.00 — trading 25.1% above its estimated fair value. The current Marketable Securities is €1,511.1 Mil. Northwest Bancshares' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Northwest Bancshares (FRA:NHS), the current Marketable Securities is €1,511.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Northwest Bancshares (FRA:NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Northwest Bancshares stock appears to be overvalued.
The current stock price of €13.00 is trading 25.1% above its estimated GF Value™ of €10.39.
GuruFocus considers Northwest Bancshares to be Modestly Overvalued.
Key valuation signals for FRA:NHS:
Marketable Securities: €1,511.1 Mil
GF Value™: €10.39 vs. price of €13.00 (25.1% above fair value)
No single metric tells the full story. See the FRA:NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
62GF Score
Get the complete analysis for FRA:NHS
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NHS has been successfully added to your 
